361 related articles for article (PubMed ID: 35806267)
1. Neuroimaging Methods to Map In Vivo Changes of OXPHOS and Oxidative Stress in Neurodegenerative Disorders.
Prasuhn J; Kunert L; Brüggemann N
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806267
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation and Mitochondrial Dysfunction in Parkinson's Disease: Connecting Neuroimaging with Pathophysiology.
Pizarro-Galleguillos BM; Kunert L; Brüggemann N; Prasuhn J
Antioxidants (Basel); 2023 Jul; 12(7):. PubMed ID: 37507950
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disorders.
Ikawa M; Okazawa H; Yoneda M
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129832. PubMed ID: 33358866
[TBL] [Abstract][Full Text] [Related]
4. [Positron Emission Tomography Imaging for Oxidative Stress in Mitochondrial and Neurodegenerative Diseases].
Ikawa M; Okazawa H; Yoneda M
Brain Nerve; 2019 Feb; 71(2):161-166. PubMed ID: 30718445
[TBL] [Abstract][Full Text] [Related]
5. Role of Neuroimaging Modality in the Assessment of Oxidative Stress in Brain: A Comprehensive Review.
Pareek V; Nath B; Roy PK
CNS Neurol Disord Drug Targets; 2019; 18(5):372-381. PubMed ID: 31580247
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Neuroimaging Techniques to Assist Clinical Trials on Cell-Based Therapies in Neurodegenerative Diseases.
Wilson H; de Natale ER; Politis M
Stem Cells; 2022 Aug; 40(8):724-735. PubMed ID: 35671344
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
8. Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson's Disease.
Pizarro-Galleguillos BM; Kunert L; Brüggemann N; Prasuhn J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430157
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria, oxidative stress and neurodegeneration.
Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial Dysfunction.
Ikawa M; Okazawa H; Nakamoto Y; Yoneda M
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32937849
[TBL] [Abstract][Full Text] [Related]
11. Brain imaging for oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.
Okazawa H; Ikawa M; Tsujikawa T; Kiyono Y; Yoneda M
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):387-97. PubMed ID: 25366710
[TBL] [Abstract][Full Text] [Related]
12. Site-specific mitochondrial dysfunction in neurodegeneration.
Vodičková A; Koren SA; Wojtovich AP
Mitochondrion; 2022 May; 64():1-18. PubMed ID: 35182728
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive imaging modalities to study neurodegenerative diseases of aging brain.
Annavarapu RN; Kathi S; Vadla VK
J Chem Neuroanat; 2019 Jan; 95():54-69. PubMed ID: 29474853
[TBL] [Abstract][Full Text] [Related]
14. Neuroimaging in Parkinsonian Disorders.
Tripathi M; Kumar A; Bal C
Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
[TBL] [Abstract][Full Text] [Related]
15. Imaging biomarkers in neurodegeneration: current and future practices.
Young PNE; Estarellas M; Coomans E; Srikrishna M; Beaumont H; Maass A; Venkataraman AV; Lissaman R; Jiménez D; Betts MJ; McGlinchey E; Berron D; O'Connor A; Fox NC; Pereira JB; Jagust W; Carter SF; Paterson RW; Schöll M
Alzheimers Res Ther; 2020 Apr; 12(1):49. PubMed ID: 32340618
[TBL] [Abstract][Full Text] [Related]
16. Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.
Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
Eur J Neurosci; 2021 May; 53(9):2946-2959. PubMed ID: 32031280
[TBL] [Abstract][Full Text] [Related]
17. Advances in Neuroimaging for Neurodegenerative Disease.
Veldsman M; Egorova N
Adv Neurobiol; 2017; 15():451-478. PubMed ID: 28674993
[TBL] [Abstract][Full Text] [Related]
18. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies.
Perani D; Iaccarino L; Lammertsma AA; Windhorst AD; Edison P; Boellaard R; Hansson O; Nordberg A; Jacobs AH;
Alzheimers Dement; 2019 Aug; 15(8):1081-1103. PubMed ID: 31230910
[TBL] [Abstract][Full Text] [Related]
19. Glial mitochondrial function and dysfunction in health and neurodegeneration.
McAvoy K; Kawamata H
Mol Cell Neurosci; 2019 Dec; 101():103417. PubMed ID: 31678567
[TBL] [Abstract][Full Text] [Related]
20. Targeting mitochondrial dysfunction in neurodegenerative disease: Part I.
Burchell VS; Gandhi S; Deas E; Wood NW; Abramov AY; Plun-Favreau H
Expert Opin Ther Targets; 2010 Apr; 14(4):369-85. PubMed ID: 20184395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
